Hepatic lipid accumulation can lead to systemic metabolic dysfunction by upregulating the expression of gluconeogenic peroxisome proliferator-activated receptor (PPAR) ligands, resulting in hyperglycemia, ketosis, and hyperlipidemia (Geng et al., 2021). Here, PPARA is linked to Hyperglycemia.